Entera Bio Ltd. (ENTX) Executive Compensation
Entera Bio Ltd. (ENTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ENTX
CIK: 1638097
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerKeren Shlomo Zaaror
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-14 | 2026-10-14 | DEF 14A | 0001178913-26-004771 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001178913-26-004720 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-23 | 2026-09-23 | PRE 14A | 0001178913-26-004572 | View SEC Doc Filr Page |
| EFFECT | 2026-08-28 | — | EFFECT Filing | 9999999995-26-002813 | View SEC Doc Filr Page |
| 424B3 | 2026-08-28 | — | 424B3 | 0001178913-26-004301 | View SEC Doc Filr Page |
| S-3 | 2026-08-21 | — | S-3 | 0001178913-26-004221 | View SEC Doc Filr Page |
| 3 | 2026-08-21 | 2026-08-18 | 3 Filing | 0001178913-26-004216 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | 8-K | 0001178913-26-004178 | View SEC Doc Filr Page |
| D | 2026-08-12 | — | D Filing | 0001638097-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003957 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003956 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003955 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003954 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003953 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003952 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003951 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003950 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-07 | FORM 4 | 0001178913-26-003949 | View SEC Doc Filr Page |
| S-8 | 2026-08-07 | — | S-8 | 0001178913-26-003948 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001178913-26-003947 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001178913-26-003946 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0001193125-26-333432 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0001013594-26-000802 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-04 | — | SCHEDULE 13D Filing | 0000921895-26-001957 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-04 | — | SCHEDULE 13G Filing | 0001193125-26-332895 | View SEC Doc Filr Page |